These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 2655530
21. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group. Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC. Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641 [Abstract] [Full Text] [Related]
22. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide. Pfaller MA, Jones RN. Diagn Microbiol Infect Dis; 1997 Aug 30; 28(4):157-63. PubMed ID: 9327242 [Abstract] [Full Text] [Related]
31. In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. Ohba F, Nakamura-Kamijo M, Watanabe N, Katsu K. Antimicrob Agents Chemother; 1997 Feb 30; 41(2):298-307. PubMed ID: 9021183 [Abstract] [Full Text] [Related]
32. In vitro activity of imipenem--a review. Braveny I. Eur J Clin Microbiol; 1984 Oct 30; 3(5):456-62. PubMed ID: 6389125 [Abstract] [Full Text] [Related]
35. In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. Neu HC, Chin NX, Novelli A. Antimicrob Agents Chemother; 1988 Nov 30; 32(11):1666-75. PubMed ID: 3150915 [Abstract] [Full Text] [Related]
36. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic. Harabe E, Kawai Y, Kanazawa K, Otsuki M, Nishino T. Drugs Exp Clin Res; 1992 Nov 30; 18(2):37-46. PubMed ID: 1644010 [Abstract] [Full Text] [Related]
37. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group. Yamaguchi K, Mathai D, Biedenbach DJ, Lewis MT, Gales AC, Jones RN. Diagn Microbiol Infect Dis; 1999 Jun 30; 34(2):123-34. PubMed ID: 10354863 [Abstract] [Full Text] [Related]
38. Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). Espinoza AM, Chin NX, Novelli A, Neu HC. Antimicrob Agents Chemother; 1988 May 30; 32(5):663-70. PubMed ID: 3293524 [Abstract] [Full Text] [Related]